A new tool to investigate differences between human SP-A1 and SP-A2

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 292, Issue 5, 2007, Pages

  Oberley, R E ^a   George, C L S ^b   Snyder, J M ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN A;

ANTIBODY SPECIFICITY; CYSTIC FIBROSIS; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG ALVEOLUS; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

CONSERVED SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVOLUTION, MOLECULAR; HUMANS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A;

EID: 34447569164     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00039.2007     Document Type: Editorial

References (25)

1. Crouch E, Hartshorn K, Ofek I. Collectins and pulmonary innate immunity. Immunol Rev 173: 52-65, 2000.
2. Goss KL, Kumar AR, Snyder JM. SP-A2 gene expression in human fetal lung airways. Am J Respir Cell Mol Biol 19: 613-621, 1998.
3. Heinrich S, Hartl D, Griese M. Surfactant protein A-from genes to human lung diseases. Curr Med Chem 13: 3239-3252, 2006.
4. Hoover RR, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 18: 353-362, 1998.
5. Inglis SK, Wilson SM. Cystic fibrosis and airway submucosal glands. Pediatr Pulmonol 40: 279-284, 2005.
6. Jack DL, Cole J, Naylor SC, Borrow R, Kaczmarski EB, Klein NJ, Read RC. Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease. Clin Infect Dis 43: 1426-1433, 2006.
7. Katyal SL, Singh G, Locker J. Characterization of a second human pulmonary surfactant-associated protein SP-A gene. Am J Respir Cell Mol Biol 6: 446-452, 1992.
8. Kim JK, Kim SS, Rha KW, Kim CH, Cho JH, Lee CH, Lee JG, Yoon JH. Expression and localization of surfactant proteins in human nasal epithelium. Am J Physiol Lung Cell Mol Physiol. In press.
9. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 43: 1293-1315, 2006.
10. Kumar AR, Snyder JM. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol Lung Cell Mol Physiol 274: L177-L185, 1998.
11. Lin Z, deMello D, Phelps DS, Koltun WA, Page M, Floros J. Both human SP-A1 and Sp-A2 genes are expressed in small and large intestine. Pediatr Pathol 20: 367-386, 2001.
12. Lofgren J, Ramet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 185: 283-289, 2002.
13. MacNeill C, Umstead TM, Phelps DS, Lin Z, Floros J, Shearer DA, Weisz J. Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid. Immunology 111: 91-99, 2004.
14. McCormick SM, Mendelson CR. Human SP-A1 and SP-A2 genes are differentially regulated during development and by cAMP and glucocorticoids. Am J Physiol Lung Cell Mol Physiol 266: L367-L374, 1994.
15. Mikerov AN, Wang G, Umstead TM, Zacharatos M, Thomas NJ, Phelps DS, Floros J. SP-A2 variants expressed in CHO-cells stimulate phagocytosis of Pseudomonas aeruginosa more than SP-A1. Infect Immun. In press.
16. Oberley RE, Snyder JM. Recombinant human SP-A1 and SP-A2 proteins have different carbohydrate-binding characteristics. Am J Physiol Lung Cell Mol Physiol 284: L871-L881, 2003.
17. Saitoh H, Okayama H, Shimura S, Fushimi T, Masuda T, Shirato K. Surfactant protein A2 gene expression by human airway submucosal gland cells. Am J Respir Cell Mol Biol 19: 202-209, 1998.
18. Sano H, Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol 42: 279-287, 2005.
19. Stuart LM, Henson PM, Vandivier RW. Collectins: opsonins for apoptotic cells and regulators of inflammation. Curr Direct Autoimmun 9: 143-161, 2006.
20. Sullivan LC, Daniels CB, Phillips ID, Orgeig S, Whitsett JA. Conservation of surfactant protein A: evidence for a single origin for vertebrate pulmonary surfactant. J Mol Evol 46: 131-138, 1998.
21. Tagaram HR, Wang G, Umstead TM, Mikerov AN, Thomas NJ, Graff GR, Hess JC, Thomassen MJ, Kavuru MS, Phelps DS, Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SPA1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol 292: in press, 2007; doi:10.1152/ajplung.00249.2006.
22. Voss T, Eistetter H, Schafer KP, Engel J. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J Mol Biol 201: 219-227, 1988.
23. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 110: 79-84, 2002.
24. Wootten CT, Labadie RF, Chen A, Lane KF. Differential expression of surfactant protein A in the nasal mucosa of patients with allergy symptoms. Arch Otolaryngol Head Neck Surg 132: 1001-1007, 2006.
25. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 77: 931-962, 1997.